Glaxo for now Saudi's sole supplier of H1N1 vaccine

RIYADH Nov 7 (Reuters) - British drugmaker GlaxoSmithKline (GSK.L) is currently Saudi Arabia's sole supplier of a vaccine for the H1N1 flu virus, the health ministry spokesman said on Saturday.

"For the moment, the only vaccine that has been authorised is the GlaxoSmithKline vaccine Pandemrix," health ministry spokesman Khaled Mirghalani told Reuters.

"We will in the future get vaccines from other clients, from other companies as soon as they get approved by the SFDA (Saudi Food and Drug Authority)," he said.

(Reporting by Nael Shyoukhi, writing by Raissa Kasolowsky; Editing by Sanjeev Miglani)